N.B.1.8.1, dubbed “razor blade throat,” is the current dominant variant in the U.S. It's an offshoot of XVD.1.5.1, which is a descendant of the omicron variant.

The Health and Human Services chief and the growing authoritarianism within the department are already seeding future danger.

COVID-19 is rising in prevalence in many states nationally following the July 4 holiday week, but the role of the main therapy to treat it — the antiviral drug Paxlovid — is less clear. Research ...

Although it has been largely phased out of U.S. vaccines, thimerosal has long been targeted by anti-vaccine advocates.

Thanks to healthcare reform, the hurdles to securing reimbursement and technology add-on payments have risen. Boston will need to invest more in clinical studies to demonstrate superiority of outcomes ...

In this week’s edition of InnovationRx, we look at Moderna’s use of quantum computers, a new top drug regulator at the FDA, ...